 | Declan P Doogan MD - Visiting Professor at Harvard School of Public Health, Professor at Glasgow University, Head of R&D Amarin Inc, >20 years at Pfizer including R&D and commercial positions, former Global Head of Development
|  | David E Slavin MD - Visiting Professor Imperial College London, Member of Risk Society, former Head, Business Innovation Unit at Pfizer, Deputy Chief Nuclear Regulator for British Navy, Occupational Health Physician
|  | Stephen A Williams MD PhD - Former head of Clinical Technology for Pfizer with ~18 years experience in exploratory development, biomarkers and imaging, ex National Advisory Council for Biomedical Imaging and Bioengineering, ex Executive Committee FNIH-FDA-PhRMA biomarker consortium
|
|  |
